| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kurt A Jellinge. Mild cognitive impairment in dementia with Lewy bodies: an update and outlook. Journal of neural transmission (Vienna, Austria : 1996). 2023-07-07. PMID:37418039. |
biomarkers are slowing of the eeg rhythms, atrophy of hippocampus and nucleus basalis of meynert, temporoparietal hypoperfusion, signs of degeneration of the nigrostriatal dopaminergic, cholinergic and other neurotransmitter systems, and inflammation. |
2023-07-07 |
2023-08-14 |
Not clear |
| Aditya Nair, Yue Yang Teo, George J Augustine, Martin Gra. A functional logic for neurotransmitter corelease in the cholinergic forebrain pathway. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 28. 2023-07-03. PMID:37399414. |
a functional logic for neurotransmitter corelease in the cholinergic forebrain pathway. |
2023-07-03 |
2023-08-14 |
Not clear |
| Aditya Nair, Yue Yang Teo, George J Augustine, Martin Gra. A functional logic for neurotransmitter corelease in the cholinergic forebrain pathway. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 28. 2023-07-03. PMID:37399414. |
such cholinergic switching between subcircuits provides a potential logic for neurotransmitter corelease in implementing behaviorally relevant computations. |
2023-07-03 |
2023-08-14 |
Not clear |
| Shangwen Jing, Xinyue Wang, Zerong Zhang, Dandan Cao, Kongli Huang, Yuting Wang, Zhuangzhuang Liu, Shijie Su, Qi Wan. Hesperetin attenuates cognitive dysfunction via SIRT6/NLRP3 pathway in scopolamine-induced mice. Metabolic brain disease. 2023-06-29. PMID:37382831. |
the levels of proinflammatory factors, oxidant stress, and the cholinergic neurotransmitter were detected by real-time quantitative fluorescence pcr (rt-qpcr) or biochemical reagent kits. |
2023-06-29 |
2023-08-14 |
mouse |
| Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, Shruti Shree, Anoop Ramachandra Bhat, Jangampalli Adi Pradeepkiran, Vasudharani Devanatha. Neurotransmitter Systems in the Etiology of Major Neurological Disorders: Emerging Insights and Therapeutic Implications. Ageing research reviews. 2023-06-29. PMID:37385351. |
neurotransmitter systems are classified as cholinergic, glutamatergic, gabaergic, dopaminergic, serotonergic, histaminergic, or aminergic systems, depending on the type of neurotransmitter secreted by the neuron, allowing effector organs to carry out specific functions by sending nerve impulses. |
2023-06-29 |
2023-08-14 |
Not clear |
| G Brand, C Bontempi, L Jacquo. Impact of deep brain stimulation (DBS) on olfaction in Parkinson's disease: Clinical features and functional hypotheses. Revue neurologique. 2023-06-10. PMID:37301657. |
the functional hypotheses also suggest complex mechanisms of cholinergic neurotransmitter interactions involved in these pathways. |
2023-06-10 |
2023-08-14 |
Not clear |
| Alexandra Ure, Georgina R Cox, Richard Haslam, Katrina William. Acetylcholinesterase inhibitors for autistic spectrum disorders. The Cochrane database of systematic reviews. vol 6. 2023-06-02. PMID:37267443. |
acetylcholine is a neurotransmitter for the cholinergic system and has a role in attention, novelty seeking, and memory. |
2023-06-02 |
2023-08-14 |
Not clear |
| Shah Alam Khan, Mohammad Jawaid Akhtar, Urvashee Gogoi, Dhanalekshmi Unnikrishnan Meenakshi, Aparoop Da. An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities. Pharmaceuticals (Basel, Switzerland). vol 16. issue 2. 2023-06-01. PMID:37259329. |
acetylcholine (ach) neurotransmitter of the cholinergic system in the brain is involved in learning, memory, stress responses, and cognitive functioning. |
2023-06-01 |
2023-08-14 |
Not clear |
| Meng Zhang, Li-Yuan Liu, Yong Xu, Wen-Zhi Wang, Nian-Zhuang Qiu, Fang-Fang Zhang, Feng Zhang, Xiao-Dan Wang, Wei Chen, Xiao-Yan Xu, Yong-Feng Gao, Mei-Hua Chen, Yu-Qin Li, Han-Ting Zhang, Hao Wan. Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer disease. Metabolic brain disease. 2023-05-31. PMID:37256468. |
the complex and diverse mechanism appears not only relevant to the imbalance of multiple neurotransmitter pathways, including the transmitters and receptors of the monoaminergic, gabaergic, histaminergic, and cholinergic systems, but also related to the changes in l-arginine and creb signaling molecules. |
2023-05-31 |
2023-08-14 |
mouse |
| Neža Žnidaršič, Malan Štrbenc, Neža Grgurevič, Tomaž Sno. Potential revival of cholinesterase inhibitors as drugs in veterinary medicine. Frontiers in veterinary science. vol 10. 2023-03-20. PMID:36937006. |
the cholinergic system is involved in the regulation of all organ systems and has acetylcholine (ach) as almost its only neurotransmitter. |
2023-03-20 |
2023-08-14 |
Not clear |
| Maria I Lazarova, Lyubka P Tancheva, Krasimira N Tasheva, Petko N Denev, Diamara N Uzunova, Miroslava O Stefanova, Elina R Tsvetanova, Almira P Georgieva, Reni E Kalfi. Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice. Journal of Alzheimer's disease : JAD. 2023-03-06. PMID:36872784. |
the neurodegenerative process in alzheimer's disease, one of the most common types of dementia worldwide, mostly affects the cholinergic neurotransmitter system and, to a lesser extent, the monoaminergic one. |
2023-03-06 |
2023-08-14 |
mouse |
| Kevin R Duque, Joaquin A Vizcarra, Emily J Hill, Alberto J Espa. Disease-modifying vs symptomatic treatments: Splitting over lumping. Handbook of clinical neurology. vol 193. 2023-02-21. PMID:36803811. |
while this convergent approach has resulted in important successes in trials of symptomatic therapies, largely aimed at correcting common neurotransmitter deficiencies (e.g., cholinergic deficiency in alzheimer's disease or dopaminergic deficiency in parkinson's disease), it has been consistently futile in trials of neuroprotective or disease-modifying interventions. |
2023-02-21 |
2023-08-14 |
human |
| Kristin R Anderson, Peter J Rogu, Talulla B Palumbo, Julie M Miw. Abnormal response to chronic social defeat stress and fear extinction in a mouse model of cholinergic dysregulation. Research square. 2023-02-13. PMID:36778356. |
the cholinergic neurotransmitter system drives attention to salient stimuli, such as stressors, and aids in orchestrating the proper neural and behavioral response. |
2023-02-13 |
2023-08-14 |
mouse |
| Hu-Jiang Shi, Shuang Wang, Xin-Ping Wang, Rui-Xin Zhang, Li-Juan Zh. Hippocampus: Molecular, Cellular, and Circuit Features in Anxiety. Neuroscience bulletin. 2023-01-21. PMID:36680709. |
studies of hippocampal neurotransmitter systems, including glutamatergic, gabaergic, cholinergic, dopaminergic, and serotonergic systems, have contributed to the interpretation of the underlying neural mechanisms of anxiety. |
2023-01-21 |
2023-08-14 |
Not clear |
| Ashok Chakraborty, Anil Diwa. Depression and Parkinson's disease: a Chicken-Egg story. AIMS neuroscience. vol 9. issue 4. 2023-01-20. PMID:36660077. |
in addition, it may involve other neurotransmitter systems such as the noradrenergic, serotonergic, cholinergic and noradrenergic systems as well. |
2023-01-20 |
2023-08-14 |
Not clear |
| Júlia L B Simões, Leilane D Sobierai, Inayá F Leal, Miriam V R Dos Santos, João Victor Coiado, Margarete D Bagatin. Action of the purinergic and cholinergic anti-inflammatory pathways on oxidative stress in patients with Alzheimer's disease in the context of the COVID-19 pandemic. Neuroscience. 2022-12-16. PMID:36526078. |
the cholinergic system, through neurons and the neurotransmitter acetylcholine (ach), modulates various physiological pathways, such as the response to stress, sleep and wakefulness, sensory information, and the cognitive system. |
2022-12-16 |
2023-08-14 |
Not clear |
| Sophia B Gibson, Elan Ness-Cohn, Erik C Anderse. Benzimidazoles cause lethality by inhibiting the function of Caenorhabditis elegans neuronal beta-tubulin. International journal for parasitology. Drugs and drug resistance. vol 20. 2022-11-04. PMID:36332489. |
subsetting neuronal expression of ben-1 based on the neurotransmitter system further restricted ben-1 function in cholinergic neurons to cause bz susceptibility. |
2022-11-04 |
2023-08-14 |
caenorhabditis_elegans |
| Faisal Alosaimi, Jackson Tyler Boonstra, Sonny Tan, Yasin Temel, Ali Jahanshah. The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson's disease. Frontiers in neuroscience. vol 16. 2022-10-24. PMID:36278000. |
furthermore, ample preclinical and clinical evidence indicates that dbs influences neurotransmitter dynamics in pd, particularly the effects of subthalamic nucleus (stn) dbs on striatal dopaminergic and glutamatergic systems; pallidum dbs on striatal dopaminergic and gabaergic systems; pedunculopontine nucleus dbs on cholinergic systems; and stn-dbs on locus coeruleus (lc) noradrenergic system. |
2022-10-24 |
2023-08-14 |
Not clear |
| Yuanyan Zi, Justin R Barker, Hugh J MacIsaac, Ruihan Zhang, Robin Gras, Ying-Chih Chiang, Yuan Zhou, Fangchi Lu, Wenwen Cai, Chunxiao Sun, Xuexiu Chan. Identification of neurotoxic compounds in cyanobacteria exudate mixtures. The Science of the total environment. 2022-10-08. PMID:36208737. |
cholinergic, dopaminergic and serotonergic neurotransmitter systems). |
2022-10-08 |
2023-08-14 |
Not clear |
| Sushmaa Chandralekha Selvakumar, K Auxzilia Preethi, Deusdedit Tusubira, Durairaj Seka. MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease. Frontiers in cellular neuroscience. vol 16. 2022-10-03. PMID:36187290. |
however, other neurotransmitter systems like serotoninergic, glutamatergic, noradrenergic, adrenergic, cholinergic, tryptaminergic, and peptidergic appear to be affected as well. |
2022-10-03 |
2023-08-14 |
Not clear |